Blends evidence depth, community direction, safety friction, and completeness.
Evidence Intensity
100/100
High depth from human/RCT/meta counts
Community Direction
100
Positive Lean • confidence Moderate
Safety Friction
64/100
Moderate signal from adverse/interaction markers
Data Completeness
100%
Studies 16 • mentions 7 • links 25
Not medical advice. This product is for educational and informational purposes only. It does not diagnose, treat, cure, or prevent any disease and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Not intended for use by pregnant or nursing women, individuals under 18, or those with known medical conditions without physician consultation.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
Implementation Blueprint
Best fit: Users with high structure tolerance and monitoring capacity..[185,1162,2780, etc.]
Goal alignment: Body Composition, Metabolic Health.[185,1162,2780, etc.]
Protocol Type
Diet Plan
Evidence Tier
HIGH
Best Fit
Users with high structure tolerance and monitoring capacity.
Primary Focus
Body Composition, Metabolic Health
Safety and Pitfalls
Higher dropout risk than moderate daily deficits in many users.[185,1162,2780, etc.]
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials.
Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial.
Effects of Different Types of Intermittent Fasting Interventions on Metabolic Health in Healthy Individuals (EDIF): A Randomised Trial with a Controlled-Run in Phase.
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial.
Any experience with alternate day fasting? I’m wondering how difficult it is, how mood can change, and if it’s actually sustainable for losing weight. I’ve done 20 hour fasts in the past for extended periods of time and curious about ADF. …
Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial **ABSTRACT** **Background:** Studies evaluating the effects of novel, alternative dietary appro…
Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial Abstract Background: Studies evaluating the effects of novel, alternative dietary approaches fo…
Currently on Day 7 of a Fast + 10 months Progress Photos Stats: 29F | 5’7” SW: 185 | CW: 154 | GW: 140 I’m on Day 7 of my 3rd annual extended fast (just water, black coffee, and electrolytes) and feeling incredible. My personal record is 8…
Was just diagnosed with Grade 2 fatty liver Hey all, I was given a rather surprising diagnosis that I have a grade 2 fatty liver incidentally when I did an ultrasound for my gall bladder (just wanted to get it checked since I have right sh…
**Background/Objectives**: Long-term alternate-day fasting (ADF) effectively combats obesity, but its short-term effects are less clear. Like other diets, ADF-induced weight loss often includes muscle loss, and whether protein supplementat…
Counts from structured PubMed protocol-specific query set.
Outcome: Humans 190, RCT 42, meta 30, cohort 7.[2780,2935,3065, etc.]
Open source 2. A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss.
PUBMED • 2023 • Human evidence curation set
PMID 36349432 from Obesity (Silver Spring).
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 3. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials.
PUBMED • 2025 • Human evidence curation set
PMID 40533200 from BMJ.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 4. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis.
PUBMED • 2018 • Human evidence curation set
PMID 29419624 from JBI Database System Rev Implement Rep.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 5. The Effect of Intermittent Fasting on Appetite: A Systematic Review and Meta-Analysis.
PUBMED • 2023 • Human evidence curation set
PMID 37299567 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 6. Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis.
PUBMED • 2023 • Human evidence curation set
PMID 37534936 from Hepatol Commun.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 7. Effects of different types of intermittent fasting on metabolic outcomes: an umbrella review and network meta-analysis.
PUBMED • 2024 • Human evidence curation set
PMID 39533312 from BMC Med.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 8. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial.
PUBMED • 2023 • Human evidence curation set
PMID 36549296 from Cell Metab.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 9. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial.
PUBMED • 2017 • Human evidence curation set
PMID 28459931 from JAMA Intern Med.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 10. Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.
PUBMED • 2019 • Human evidence curation set
PMID 31471173 from Cell Metab.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 11. Intermittent Fasting in Weight Loss and Cardiometabolic Risk Reduction: A Randomized Controlled Trial.
PUBMED • 2022 • Human evidence curation set
PMID 35050952 from J Nurs Res.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 12. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity.
PUBMED • 2023 • Human evidence curation set
PMID 36868222 from Cell Metab.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 13. A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults.
PUBMED • 2021 • Human evidence curation set
PMID 34135111 from Sci Transl Med.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 14. Effects of Different Types of Intermittent Fasting Interventions on Metabolic Health in Healthy Individuals (EDIF): A Randomised Trial with a Controlled-Run in Phase.
PUBMED • 2024 • Human evidence curation set
PMID 38674802 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 15. Picalm, a novel regulator of GLUT4-trafficking in adipose tissue.
PUBMED • 2024 • Human evidence curation set
PMID 39182843 from Mol Metab.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 16. Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial.
PUBMED • 2018 • Human evidence curation set
PMID 30046988 from Adv Ther.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]
Open source 17. Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention.
PUBMED • 2025 • Human evidence curation set
PMID 40371575 from J Am Heart Assoc.
Outcome: See linked PubMed abstract for methods and outcomes.[2780,2935,3065, etc.]